India, Oct. 30 -- Hikal Limited has announced that its active pharmaceutical ingredient (API) manufacturing facility in Bengaluru has received a Certificate of GMP Compliance from Swissmedic, the Swiss Agency for Therapeutic Products.
The certification confirms that the facility complies with Good Manufacturing Practice (GMP) requirements under the Mutual Recognition Agreement between the European Union and Switzerland.
The latest recognition follows successful inspections of the Bengaluru facility by Brazil's ANVISA and Japan's PMDA, further strengthening Hikal's credentials with global regulatory authorities. The certification is expected to help the company expand its customer base across regulated markets, particularly Europe, while s...